Home About Us Contact Us

 

Table of Content - Volume 20 Issue 1 - October 2021


 

Study of laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction

 

Varsha Sapehia1, Kamlesh2*, Prerna Verma3, Kajal Jain4, Tanvir Samra5, Komal Ghandhi6, lileshwar Kaman7

 

1Junior Resident, 3,6Assistant Professor, 4Professor, 5Associate Professor, Department of Anaesthesia & Intensive Care}

{7Professor, Department of General Surgery} PGIMER, Chandigarh, INDIA.

2Junior Resident, Department of Obstetrics & Gynaecology, Kamla Nehru Hospital, Shimla, Himachal Pradesh, INDIA.

Email: varshasapehia@gmail.com

 

Abstract              Background: Laparoscopic cholecystectomy procedure results cosmetically more acceptable , decreased hospital duration, less postoperative pain and lesser disability from daily work as compared to open cholecystectomy .Intensive intraoperative monitoring and vigilance in the anesthetic management is of utmost importance for a smooth perioperative course in patients with cardiac dysfunction. In present study, we studied laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction at a tertiary hospital. Material and Methods: Present study was single-center, open label, prospective, observational controlled study, conducted in patients 18-65 years, either gender, with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, willing to participate in present study. Results: 15 patients with moderate to severe LV dysfunction undergoing laparoscopic cholecystectomy were enrolled in the study. In present study, mean age was 55.57 ± 7.52 years. Gender wise male (26.67 %) were less than female (73.3 %) patients. Medical comorbidities were Hypertension (80 %), Diabetes mellites 3 (20 %) and Previous history of cardiac intervention (20 %). 73.3 % patients had moderate Left ventricular dysfunction (LVEF 36–40%) while 26.67 % had severe Left ventricular dysfunction (LVEF < 36%).The mean HR values, decrease in mean HR was 6.5% On intragroup statistical analysis, no significant change in mean HR is seen at T2, T3, T4 or T5 from T1 was noted. From T1 to T2, the fall in mean MAP was 9.7% while from T2 to T3, 32.5% increase in MAP was seen. On intragroup statistical analysis, no significant change in mean MAP was noted. Out of the 15 patients in the study group, 4 patients had episodes of hypotension, 1 patient in had an episode of bradycardia requiring intervention. No significant complications occurred during immediate postoperative period as well as during the hospital stay. On 3 month follow up of these patient (telephonically), no mortality or morbidity has been recorded. Conclusion: cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist. Optimization of cardiac status, administered of balanced anaesthesia and 10-12 mmHg pressure pneumoperitoneum are essential steps for patients’ safety. Life threatening complications are low and can be easily managed in hospital with adequate cardiology support.

Keywords: laparoscopic cholecystectomy, left ventricular systolic dysfunction, balanced anaesthesia, pneumoperitoneum

 

INTRODUCTION

Over the years surgical skills have been improved and also there is better understanding of pneumoperitoneum so now laparoscopic cholecystectomy is done by most of the surgeons. Laparoscopic cholecystectomy procedure results cosmetically more acceptable, decreased hospital duration, less postoperative pain and lesser disability from daily work as compared to open cholecystectomy.1 But in patients with moderate to severe left ventricular dysfunction whether the laparoscopic cholecystectomy is beneficial as it will cause less physiological stress or there will be cardiovascular disadvantage of pneumoperitoneum, is a matter of concern for both laparoscopic surgeon and anesthetist. Intensive intraoperative monitoring and vigilance in the anesthetic management is of utmost importance for a smooth perioperative course in patients with cardiac dysfunction.2,3 This requires a thorough knowledge into the effect of pneumoperitoneum and reverse Trendelenburg positioning on the cardiac physiology especially with respect to patients with a diseased myocardium.4,5 In present study, we studied laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction at a tertiary hospital.

 

MATERIAL AND METHODS

Present study was single-center, open label, prospective, observational controlled study, conducted in Department of Anaesthesia & Intensive Care, PGIMER, Chandigarh, India. Study period was April, 2019 to March, 2020 (1 year). After approval from the Institute Ethics Committee and written informed consent (prior to enrolment) of the participants, present study was conducted.

Inclusion criteria: Patients 18-65 years, either gender, with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, willing to participate in present study.

Exclusion criteria: BMI > 35 kg/m2. Coexisting stenotic valve lesions or right ventricular dysfunction. Presence of electrocardiographic findings of arrhythmia. NYHA IV physical status. End stage hepatic/renal/pulmonary disease

Demographic variables, history of cardiac medications and prior history of admission to the ER or cardiac adverse events was noted. Patients were evaluated as per standard operative procedures for laparoscopic surgery,

The formal echocardiography was done by an experienced cardiologist and LV systolic dysfunction was graded as mild (LVEF 41–45%), moderate (LVEF 36–40%), or severe (LVEF < 36%).6

In operation theatre, standard ASA monitors including 5 lead ECG, pulse oximeter and NIBP were attached and baseline echocardiography was done. A broad gauge intravenous cannula was placed in the right internal jugular vein and connected to the pressure transducing system (Edward Life Science) for central venous pressure(CVP) measurement. Under aseptic conditions and local anaesthetic, a 20G arterial cannula was inserted in the radial artery and connected to the FloTrac system for continuous cardiac output, SVV monitoring. CVP measured from the venous cannula was also transduced for calculation of SVR. A baseline ABG sample was taken at T1 for measurement of baseline PaCO2.

Under general anaesthesia, after creation of pneumoperitoneum, once IAP of 12mm Hg was achieved, 2D echocardiography was done (T2). Intraoperatively IAP was maintained to < 12 mmHg. Following this reverse Trendelenburg positioning was done. 10 min after the positioning the 2nd sample of ABG was taken. IBP, HR, MAP, SpO2, EtCO2, intra abdominal pressures were monitored continuously. CO (both from 2D echo, FloTrac system), IBP, NIBP, HR, SVV, CVP, SVR, SPV, PPV were noted at the predefined study time points. After 10 min after desufflation (T5), third ABG sample was taken. All study parameters were recorded at the following time points.

  • T1 - Pre-induction
  • T2 - 10 minute after induction
  • T3 - when pneumoperitoneum with intra-abdominal (IAP) pressure of 12mm Hg is achieved,
  • T4 - 10 minute after reverse Trendelenburg position,
  • T5 - 10 minute after deflation of pneumoperitoneum.

The patient was shifted to PACU after fulfilling the criteria that patient was able to respond to verbal stimuli and ensuring that pain was adequately managed. Any post procedure nausea and vomiting were addressed and anti-emetics were prescribed. All cardiac patients were followed till hospital discharge and any in hospital morbidity were noted. Any patients with symptoms suggestive of failure or ischemic event in the postoperative period were subjected to quantitative analysis of cardiac biomarkers. 30-day morbidity and mortality were for telephonic communication with the patients.

Data was collected and compiled using Microsoft Excel, analysed using SPSS 23.0 version. Difference of proportions between qualitative variables were tested using chi- square test or Fisher exact test as applicable. P value less than 0.5 was considered as statistically significant.

 

RESULTS

15 patients with moderate to severe LV dysfunction undergoing laparoscopic cholecystectomy were enrolled in the study. In present study, mean age was 55.57 ± 7.52 years. Gender wise male (26.67 %) were less than female (73.3 %) patients. Medical comorbidities were Hypertension (80 %), Diabetes mellites 3 (20 %) and Previous history of cardiac intervention (20 %). 73.3 % patients had moderate Left ventricular dysfunction (LVEF 36–40%) while 26.67 % had severe Left ventricular dysfunction (LVEF < 36%).


 

 

Table 1: Demographic characteristics of both groups

Parameter

No. of cases (%)/ Mean ± SD

Age in years

55.57 ± 7.52

Gender

 

Male

4 (26.67 %)

Female

11 (73.3 %)

Weight in kg

64.43±14.62

Height in cm

164.29±11.15

BMI in kg/m2

23.66±2.77

BSA in m2

1.7±0.25

Medical comorbidities

 

Hypertension

12 (80 %)

Diabetes mellites

3 (20 %)

Previous history of cardiac intervention

3 (20 %)

Left ventricular dysfunction

 

Moderate (LVEF 36–40%)

11 (73.3 %)

Severe (LVEF < 36%)

4 (26.67 %)

The mean HR values, decrease in mean HR was 6.5% On intragroup statistical analysis, no significant change in mean HR is seen at T2, T3, T4 or T5 from T1 was noted.

 

Table 2: Heart rate at the defined time points of the study.

Heart rate (beats/min)

Mean ± SD

P value from T1

HR at T1

81±10.82

-

HR at T2

75.71±12.84

.411

HR at T3

74.29±14.16

.338

HR at T4

75.43±15.21

.464

HR at T5

71.86±13.31

.106

From T1 to T2, the fall in mean MAP was 9.7% while from T2 to T3, 32.5% increase in MAP was seen. On intragroup statistical analysis, no significant change in mean MAP was noted.

 

Table 3: Mean arterial pressure at defined time points of the study

Mean arterial pressure (mm Hg)

Mean ± SD

P value from T1

MAP at T1

92±12.81

-

MAP at T2

83±13.18

.316

MAP at T3

102.43±16.46

.083

MAP at T4

97.57±13.15

.368

MAP at T5

97.29±13.95

.472

From T1 to T2, the increase in mean CVP was 29.3% and mean CVP values decrease from T4 to T5 and reach values approximately similar to the T1 levels. On intragroup statistical analysis, significant increase in mean CVP was seen at T3, T4 from T1.

Table 4: Mean CVP at the defined time points of the study.

Central venous pressure (mm Hg)

Mean ± SD

P value from T1

CVP at T1

7.86±2.41

-

CVP at T2

10.14±4.71

.121

CVP at T3

12.86±3.24

.006

CVP at T4

12.57±3.26

.008

CVP at T5

8.57±3.21

.593

From T1 to T2, no change in mean SVR was seen, while from T2 to T3 and T4, there was an increase in the mean SVR, mean SVR values at T5 return to the approximately the T1 levels after CO2 exsufflation.

 

Table 5: Mean SVR at the defined time points of the study.

Systemic vascular resistance (Dynes.sec.cm-5)

Mean ± SD

P value from T1

SVR at T1

1503.71±674.3

-

SVR at T2

1505±463.33

.995

SVR at T3

1988.86±755.96

.041

SVR at T4

1970.57±629.86

.058

SVR at T5

1702.86±849.44

.387

From T1 to T2, the fall in mean CO was 15.9% while at T3 9.7% (from T2) fall in CO was noticed and the CO does return to similar pre-induction T1 values at T5.

Table 6: Mean cardiac output at the defined time points of the study.

Cardiac output (L/min)

Mean ± SD

P value from T1

CO at T1

4.98±1.46

-

CO at T2

4.19±1.33

.180

CO at T3

3.78±1.12

.092

CO at T4

3.71±1.13

.067

CO at T5

4.66±1.3

.507

The mean EtCO2 values were statistically significant when compared from P1 values.

 

Table 7: Mean EtCO2 in the two groups at the defined time points of the study.

EtCO2 (mm Hg)

Mean ± SD

P value from T1

EtCO2 at T1

29.86±2.34

-

EtCO2 at T2

35.43±5.32

.011

EtCO2 at T3

34.71±5.94

.045

EtCO2 at T4

37.29±4.57

.006

EtCO2 at T5

37.57±5.86

.012

The PaCO2 values were comparable between predefined time points in the study.

 

TABLE 8: Mean PaCO2 in the two groups at the defined time points of the study.

PaCO2 (mm Hg)

Mean ± SD

P value from T1

PaCO2 at T1

36.19±6.75

-

PaCO2 at T4

39.86±4.95

.249

PaCO2 at T5

39.69±6.71

.354

Out of the 15 patients in the study group, 4 patients had episodes of hypotension, 1 patient in had an episode of bradycardia requiring intervention. No significant complications occurred during immediate postoperative period as well as during the hospital stay. On 3 month follow up of these patient (telephonically), no mortality or morbidity has been recorded.

 


DISCUSSION

Pneumoperitoneum stimulate a neuro-hormonal stress response which lead to increases heart rate, mean arterial blood pressure and systemic vascular resistance.1 Myocardial oxygen demand is increased by these factors having deletiorus effects on patients having cardiac dysfunction.7 Venous return and preload is decreased by increased intra-abdominal pressure and reverse Trendelenburg position , and it increases afterload which would eventually increase cardiac burden. These could precipitate cardiac ischemia or infarction. With pneumoperitoneum the variation in cardiovascular parameters will depend on the patient's intravascular volume, the ventilatory technique , anesthetic agents employed, rate insufflations on the intra-abdominal pressure attained , amount of CO2 absorbed and patient characteristics.8 The hemodynamic consequences of intraoperative hypercarbia were addressed by Rasmussen et al. In a study of 12 patients with ischemic heart disease in whom PaCO2 levels reached to 55-65 mmHg and resulted in a significant increase in heart rate, systolic blood pressure and cardiac output .It was also suggested the two- to threefold increase in plasma catecholamine concentrations due to sympathetic nervous system stimulation because of hypercarbia.9According to the demographic data, the patients belong to a significantly older age group (55± 7 years), which can be very well explained by the fact that incidence of LV systolic dysfunction and hypertension increases significantly with age.10 Patients in the study per se are predominantly females (72%). A population based study done in the north Indian population confirms a greater prevalence of cholecystitis in females as compared to males. 11 Dhoste et al.,12 in a similar study evaluated the hemodynamic and respiratory changes during laparoscopic cholecystectomy in patients aged >75 years, ASA III category and concluded that the main cardiovascular depression was noted after induction of anesthesia14. In their study the CI dropped by 41%, MAP by 27% while the HR by 20% from the baseline value. The fall in these hemodynamic parameters is greater as compared to observations in our study. This difference in results could be because of titrated and graded induction of anesthesia, along with rescue pharmacological interventions done to maintain the hemodynamic parameters. We relied on echocardiographic parameters for measurement of CO; a pulmonary artery catheter was utilized by Dhoste et al. Various noninvasive monitoring techniques are available to obtain a better insight into the pathophysiological effects of creation of pneumoperitoneum. TTE is a non invasive, cost effective technique which gives us a quick, repeatable and reliable real time image of the ongoing changes in cardiac function as well as helps us in early diagnosis of the cause of any adverse hemodynamic event encountered during surgery. It also serves as a good guide in perioperative management.13 Tools like transthoracic echocardiography and dynamic fluid responsiveness monitoring using IABP or FloTrac (Edwards Life Sciences, Irvine, CA, USA) done perioperatively come in handy in these clinical scenarios. Present study intends to project that patients with moderate to severe systolic dysfunction can also undergo cholecystectomy using the laparoscopic technique keeping in mind the various changes in cardiac output and different stages of the surgery. A tailored anaesthetic technique keeping in mind the physiological changes of pneumoperitoneum, limited pneumoperitoneum time, and anesthetic as well as surgical expertise play a very important role in achieving stable hemodynamics perioperatively. The expertise of surgeon (same surgeon performing all the procedures) and an average time of pneumo-peritoneum of 29 minutes significantly reduce the duration of exposure of the patients with impaired left ventricular systolic function to the deleterious effects of pneumoperitoneum.

 

CONCLUSION

Present study showed that laparoscopic cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist. Optimization of cardiac status, administered of balanced anaesthesia and 10-12 mmHg pressure pneumoperitoneum are essential steps for patients’ safety. Life threatening complications are low and can be easily managed in hospital with adequate cardiology support.

 

REFERENCES

  • Rubert CP, Farias FV, Higa RA. Comparison between open and laparoscopic elective cholecystectomy in elderly, in a teaching hospital. Rev Col Bras Cir 2016;43:2–5.
  • Silverstein A, Costas A, Gakwaya MR, Lule J, Meara JG, Shrime MG, et al. Laparoscopic versus open cholecystectomy: A Cost-Effectiveness Analysis at Rwanda Military Hospital. world J Surgery. 2017;41:1225–33.
  • Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, et al. Complications of laparoscopic cholecystectomy: Our experience from a retrospective analysis. Maced J Med Sci. 2016; 4:641-646.
  • Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135:700-710
  • Umar A, Mehta KS, Mehta N. Evaluation of hemod
  • ynamic changes using different intra-abdominal pressures for laparoscopic cholecystectomy. Indian J Surg. 2013; 75:284-289
  • Narayan K, Oommen R, Thomson V.S, Jose JV Assessment of left ventricular systolic function by velocity vector imaging. Indian Heart J. 2012;64:146–9
  • Tekelioglu UY, Erdem A, Demirhan A, Akkaya A, Ozturk S, Bilgi M, et al. The prolonged effect of pneumoperitoneum on cardiac autonomic functions during laparoscopic surgery; Eur Rev Med Pharmacol Sci. 2013; 17:895-902.
  • Sadhu S, Sarkar S, Jahangir TA, Verma R, Shaikh F, Dubey SK, et al. Laparoscopic cholecystectomy in patients with cardiac dysfunction. Indian J Surg. 2011;73:90-95
  • Rasmussen JP, Dauchot PJ, Depalma RG, Sorensen B, Regula G, Anton AH, et al. Cardiac function and hypercarbia. Arch Surg. 1978; 113;1196-1200.
  • I Raymond, F Pedersen, F Sten Sgaard, A Green M, Bush, C Tuxen etal. Prevalence of impaired left ventricular systolic functiong and heart failure. J Heart 2003; 89: 1422-9
  • Sayeed U, Palepu J, Vinay D, Chiranjeeva K, Latendu S Tarun KR etal. Population-based study to estimate prevalence and determine risk factors of gall bladder. HPB Oxford. 2011; 13: 117-125
  • Dhoste K, Lacoste L, Karayan J, Lehuede MS, Thomas D, Fusciardi J. Haemodynamic and ventilatory changes during laparoscopic cholecystectomy in elderly ASA III patients. Can J Anaesth. 1996; 43:783-788.
  • Jørgensen MRS, Juhl-Olsen P, Frederiksen CA, Sloth E. Transthoracic echocardiography in the perioperative setting. Curr Opin Anaesthesiol. 2016; 29:46-54.





























 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.